Avidian Wealth Enterprises’s AbCellera Biologics ABCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
Sell
-12,600
Closed -$180K 480
2021
Q4
$180K Sell
12,600
-1,800
-13% -$25.7K 0.01% 490
2021
Q3
$289K Buy
+14,400
New +$289K 0.02% 297
2021
Q2
Sell
-13,000
Closed -$441K 375
2021
Q1
$441K Buy
+13,000
New +$441K 0.04% 229